The type and number of SC for MRSA analysis_
| Maribor | Celje | Kranj | Total | |
|---|---|---|---|---|
| The number of received SC | 32,389 | 21,500 | 11,362 | 65,251 |
| The number of positive SC | 430 | 492 | 311 | 1,233 |
| The % of positive SC | 1.3% | 2.3% | 2.7% | 1.9% |
| The number of SSS | no data - the data management in Maribor did not allow to group the swabs of MRSA negative patients into “Surveillance sample set (SSS)”. | 7,105 | 3,565 | / |
| The number of positive SSS | 231 | 260 | 170 | 661 |
| The % of positive SSS | no data - the data management in Maribor did not allow to group the swabs of MRSA negative patients into “Surveillance sample set (SSS)”. | 3.7% | 4.8% | / |
| The number of examined persons - if repeated surveillance swabs were received from a single patient, such patient was counted once only | 6,141 | 5,050 | 2,083 | 13,274 |
| The number of positive persons - each MRSA positive patient was counted once only | 152 | 203 | 135 | 490 |
| The % of positive persons | 2.5% | 4.0% | 6.5% | 3.7% |
| Positive SC in one anatomic site | 101 | 106 | 83 | 290 |
| Positive SC in two anatomic sites | 65 | 80 | 45 | 190 |
| Positive SC in three anatomic sites | 58 | 72 | 34 | 164 |
| Positive SC in four or more anatomic sites | 7 | 2 | 8 | 17 |
NOSE (the original questionnaire)_
| Category | Anatomic sites | ||||
|---|---|---|---|---|---|
| Nose | Nose | Naso-pharynx | |||
| Perineum | Perineum | Anus | Perianal | Rectum | |
| Skin | Skin | Groin | Axilla | Ear | Swabs of stoma (tracheostoma, gastrostoma, ileostoma and colostoma), cannula and tubus |
| Wound | Wound | Pressure sore | Lesion | ||
| Tracheal aspirate | Trachea aspirate | Trachea swabs | |||
| Urine | Urine | ||||
| Faeces | Excreta | ||||
The sensitivty of surveillance cultures regarding the anatomical location and combination of swabs_A MRSA positive locations in the nose, throat, perineum (NTP) set_
| A combination of locations | Total(%) |
|---|---|
| The number of MRSA positive patients with the nose, throat, perineum set | 189 (100) |
| The number of patients with the MRSA in all three swabs | 59 (31.2) |
| The number of patients with the MRSA in the nose and perineum | 23 (12.2) |
| The number of patients with the MRSA in the nose and throat | 18 (9.5) |
| The number of patients with the MRSA in the throat and perineum | 8 (4.2) |
| The number of patients with the MRSA in the nose only | 28 (14.8) |
| The number of patients with the MRSA in the perineum only | 29 (15.3) |
| The number of patients with the MRSA in the throat only | 24 (12.7) |
The sensitivity of different combinations of surveillance swabs included in the NTP SSS_
| SSS | Sensitivity |
|---|---|
| NTS | 100 |
| NT | 75.0 |
| NS | 87.0 |
| TP | 75.0 |
| N | 66.7 |
| T | 59.1 |
| S | 34.0 |
MRSA positive locations in the SSS NTS_
| A combination of locations | Total (%) |
|---|---|
| The number of MRSA positive patients with the NTS set | 276 (100) |
| The number of patients with the MRSA in all three swabs | 74 (26.8) |
| The number of patients with the MRSA in the nose and skin | 35 (12.7) |
| The number of patients with the MRSA in the nose and throat | 40 (14.5) |
| The number of patients with the MRSA in the throat and skin | 13 (4.7) |
| The number of patients with the MRSA in the nose only | 35 (12.7) |
| The number of patients with the MRSA in the skin only | 43 (15.6) |
| The number of patients with the MRSA in the throat only | 36 (13.0 ) |
The type and number of surveillance cultures (SC) sent for the MRSA detection, and the proportion of positive results_
| SAMPLE | Total(%) | Positive (%) | % of positive swabs taken form this location |
|---|---|---|---|
| Nasal swab | 20,378 (31.2) | 418 (33.9) | 2.1 |
| Throat swab | 20,426 (31.3) | 363 (29.4) | 1.8 |
| Skin swab | 12,319 (18.9) % | 228 (18.5) | 1.9 |
| Perineum swab | 10,707 (16.4) | 161 (13.1) | 1.5 |
| Wound swab | 894 (1.4) | 52 (4.2) | 5.8 |
| Tracheal aspirate/sputum | 200 (0.3) | 3 (0.2) | 1.5 |
| Vaginal swab | 13 (0.0) | 0 (0.0) | 0.0 |
| Urine | 289 (0.4) | 4 (0.3) | 1.4 |
| Stool | 25 (0.0) | 4 (0.3) | 16.0 |
| TOTAL | 65,251 (100) | 1233 (100) | 1.9 |